DocDollars

Morphosys AG

Germany · Reporting entity ID 100000971878

Total reported 2019–2025
$12.0M
#441 of 2,960 reporting companies — 0% of all reported industry payments
$80K in general payments across 42 records, plus $12.0M in research funding across 2,732 records.

How it breaks down

General payments $80,198
Research funding $11,965,171

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Morphosys AG reported $12.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #441 of 2,960 reporting companies. 99% of that was research funding and 1% general payments such as consulting, speaking, food and travel. 42 general payment records and 2,732 research records were filed.

Common questions about Morphosys AG

How much has Morphosys AG paid US doctors?

Morphosys AG reported $12,045,368 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $80,198 in general payments, $11,965,171 in research funding.

How does Morphosys AG rank among drug and device companies?

It ranks #441 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Morphosys AG mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.